What's breaking now, across thousands of outlets.
The FDA approved a novel drug to reduce recurrence of stroke, the agency is warning that GLP-1s carry a potential risk for an eye condition, and more pharma news of…
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
At Walk in New York, patients with spinal cord injuries are walking again in Wandercraft’s Atalante X, a rehab exoskeleton that balances itself. Its home sibling, Eve, cleared the FDA in August.
As traditional multigenerational households have become less common, increasing numbers of older adults are living alone or with only their spouses.
Brave faces, powerful stories and a message of hope for anyone touched by cancer: a new photo exhibition has opened […]
[Ghanaian Times] Ghanaian health and human services executive, Dr Isaac Mawuko Adusu, has received the 2026 Excellence in Health Administration Award from the Health Administration Section of the…
The FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.”
Many solid tumors, including many cancers of the pancreas, breast, colon and lung, protect themselves with a dense wall of scar-like tissue.
